TGFB1 and Hepatic fibrosis: The elevated plasma VDR levels may indicate increased VDR activity, which has been reported to inhibit liver fibrosis by suppressing the TGF-β1/SMAD signaling-mediated expression of pro-fibrotic genes [47].